Die TFDA genehmigt NaoTrac, den ersten autonomen neurochirurgischen Navigationsroboter von Brain Navi Biotechnology ...Middle East

HSINCHU, 8. August 2022 /PRNewswire/ -- NaoTrac, der CE-zertifizierte neurochirurgische Navigationsroboter, erhielt im Juli 2022 die Zulassung von der taiwanesischen Lebensmittel- und Arzneimittelbehörde (TFDA) und wird voraussichtlich bis Ende 2022 bei der FDA (der US-amerikanischen...

Hence then, the article about die tfda genehmigt naotrac den ersten autonomen neurochirurgischen navigationsroboter von brain navi biotechnology was published today ( Monday 08/08/2022 - 05:08 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Die TFDA genehmigt NaoTrac, den ersten autonomen neurochirurgischen Navigationsroboter von Brain Navi Biotechnology )

Also on site :

• Gulf nations hoped to move beyond oil. The Iran war made that much harder.
• MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
• RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear